ZA200005134B - Solid, quick dissolving cetirizine formulations. - Google Patents

Solid, quick dissolving cetirizine formulations.

Info

Publication number: ZA200005134B
Authority: ZA; South Africa
Prior art keywords: solid; quick dissolving; cetirizine formulations; dissolving cetirizine; formulations
Prior art date: 1998-03-31

Application number

ZA200005134A

Other languages

English (en)

Inventor

Wolfram Tritthart

Mario Andre Piskernig

Original Assignee

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-31

Filing date

2000-09-26

Publication date

2000-12-21

2000-09-26 Application filed by Asta Medica Ag filed Critical Asta Medica Ag

2000-12-21 Publication of ZA200005134B publication Critical patent/ZA200005134B/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Immunology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Cephalosporin Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

ZA200005134A 1998-03-31 2000-09-26 Solid, quick dissolving cetirizine formulations. ZA200005134B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19814256A DE19814256A1 (de)	1998-03-31	1998-03-31	Feste, schnellzerfallende Cetirizin-Formulierungen

Publications (1)

Publication Number	Publication Date
ZA200005134B true ZA200005134B (en)	2000-12-21

Family

ID=7863014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200005134A ZA200005134B (en)	1998-03-31	2000-09-26	Solid, quick dissolving cetirizine formulations.

Country Status (31)

Country	Link
US (1)	US6245353B1 (xx)
EP (1)	EP1067904B1 (xx)
JP (1)	JP2002509873A (xx)
KR (1)	KR100653568B1 (xx)
CN (1)	CN1136838C (xx)
AR (1)	AR018828A1 (xx)
AT (1)	ATE209899T1 (xx)
AU (1)	AU750140B2 (xx)
BG (1)	BG64741B1 (xx)
BR (1)	BR9909233A (xx)
CA (1)	CA2326809C (xx)
CY (1)	CY1107331T1 (xx)
CZ (1)	CZ300704B6 (xx)
DE (2)	DE19814256A1 (xx)
DK (1)	DK1067904T3 (xx)
ES (1)	ES2168013T3 (xx)
HK (1)	HK1036217A1 (xx)
HU (1)	HU227477B1 (xx)
IL (1)	IL138606A (xx)
NO (1)	NO329071B1 (xx)
NZ (1)	NZ506988A (xx)
PL (1)	PL191266B1 (xx)
PT (1)	PT1067904E (xx)
RU (1)	RU2216318C2 (xx)
SI (1)	SI1067904T1 (xx)
SK (1)	SK284476B6 (xx)
TR (1)	TR200002809T2 (xx)
TW (1)	TWI233808B (xx)
UA (1)	UA57615C2 (xx)
WO (1)	WO1999049843A1 (xx)
ZA (1)	ZA200005134B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7105501A (en) *	2000-07-17	2002-01-30	Yamanouchi Pharma Co Ltd	Pharmaceutical composition improved in peroral absorbability
EP1467715B1 (en) *	2002-01-15	2010-11-03	Ucb Farchim S.A.	Formulations for oral administration of active compounds
WO2003084511A1 (en) *	2002-04-04	2003-10-16	Pfizer Products Inc.	Palatable chewable tablet
AU2005247048B2 (en) *	2004-05-28	2007-12-13	Imaginot Pty Ltd	Oral therapeutic compound delivery system
US8216610B2 (en)	2004-05-28	2012-07-10	Imaginot Pty Ltd.	Oral paracetamol formulations
US8758816B2 (en) *	2004-11-24	2014-06-24	Meda Pharmaceuticals Inc.	Compositions comprising azelastine and methods of use thereof
DK2377557T3 (en)	2004-11-24	2017-02-06	Meda Pharmaceuticals Inc	Compositions comprising azelastine and methods for its use
US20070020330A1 (en)	2004-11-24	2007-01-25	Medpointe Healthcare Inc.	Compositions comprising azelastine and methods of use thereof
US20060198885A1 (en) *	2005-02-22	2006-09-07	Sun Pharmaceutical Industries Ltd.	Oral pharmaceutical composition
EP3449928A1 (en)	2005-11-28	2019-03-06	Imaginot Pty Ltd.	Oral therapeutic compound delivery system
RU2011112926A (ru) *	2008-09-05	2012-10-10	МакНЕЙЛ-ППС, ИНК. (US)	Способ изготовления таблеток цетиризина
EP2405747A4 (en) *	2009-03-13	2013-01-16	Nucitec Sa De Cv	COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
EP2571484A2 (en) *	2010-05-18	2013-03-27	Mahmut Bilgic	Effervescent formulations
RU2014149581A (ru)	2012-06-12	2016-07-10	Дзе Проктер Энд Гэмбл Компани	Шипучая лекарственная форма
US20140371174A1 (en)	2013-06-12	2014-12-18	The Procter & Gamble Company	Effervescent Dosage Form
JP5945191B2 (ja) *	2012-08-09	2016-07-05	株式会社ファンケル	口腔内速崩錠
JP6092672B2 (ja) *	2013-03-21	2017-03-08	株式会社ファンケル	口腔内速崩壊性錠剤
KR101591319B1 (ko) *	2013-12-03	2016-02-18	에프엔바이오 주식회사	홍삼 발포정의 제조방법
TWI732337B (zh) *	2014-06-20	2021-07-01	美商梅琳塔有限責任公司	醫藥組成物及其用途
TW201605447A (zh) *	2014-06-20	2016-02-16	美林塔治療學有限公司	處理感染的方法
EP3061501A1 (en)	2015-02-27	2016-08-31	Rottapharm Ltd.	Composition for the treatment of acne
EP3117825A1 (en)	2015-07-16	2017-01-18	Rottapharm S.p.A.	Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) *	2016-07-28	2016-11-16	北京万全德众医药生物技术有限公司	盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en)	2016-11-15	2020-04-21	Berkeley Nox Limited	Dietary supplements
JP2018108950A (ja) *	2016-12-28	2018-07-12	沢井製薬株式会社	レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) *	2017-11-15	2019-05-23	Berkeley Nox Limited	Novel dietary supplements
EP3799864B1 (en)	2019-10-02	2023-03-01	Intas Pharmaceuticals Limited	Essentially sodium-free effervescent solid pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI75816C (fi) *	1981-02-06	1988-08-08	Ucb Sa	Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4678661A (en) *	1983-09-28	1987-07-07	Gerhard Gergely	Effervescent composition and method of making same
US4792448A (en) *	1987-06-11	1988-12-20	Pfizer Inc.	Generic zero order controlled drug delivery system
IL91398A (en) *	1988-08-30	1994-05-30	Pfizer	A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5178878A (en)	1989-10-02	1993-01-12	Cima Labs, Inc.	Effervescent dosage form with microparticles
EP0542926B1 (en) *	1990-08-07	1995-02-15	Pfizer Inc.	Use of interfacially-polymerized membranes in delivery devices
HU219242B (en) *	1991-05-13	2001-03-28	Boots Co Plc	S(+)-ibuprofen sodium salt dihydrate, pharmaceutical composition comprising this compound and process for production of them
MX9300110A (es) *	1992-01-13	1994-07-29	Gerhard Gergely	Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
WO1994008551A2 (en) *	1992-10-09	1994-04-28	The Procter & Gamble Company	Pharmaceutical compositions and methods for treating cold symptoms
GB9224021D0 (en) *	1992-11-16	1993-01-06	Boots Co Plc	Effervescent compositions
FR2698788B1 (fr) *	1992-12-09	1995-03-03	Union Pharma Scient Appl	Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) *	1992-12-25	2000-08-11	Senju Pharma Co	Antiallergic composition for ophthalmic or nasal use
EP0624364B1 (de) *	1993-04-15	1996-07-24	Gerhard Dr. Gergely	Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
JPH08509725A (ja) *	1993-04-30	1996-10-15	ザ、プロクター、エンド、ギャンブル、カンパニー	コートされた医薬組成物
US5458879A (en) *	1994-03-03	1995-10-17	The Procter & Gamble Company	Oral vehicle compositions

1998
- 1998-03-31 DE DE19814256A patent/DE19814256A1/de not_active Withdrawn
1999
- 1999-03-20 KR KR1020007010848A patent/KR100653568B1/ko not_active IP Right Cessation
- 1999-03-20 RU RU2000127709/14A patent/RU2216318C2/ru not_active IP Right Cessation
- 1999-03-20 AU AU39253/99A patent/AU750140B2/en not_active Ceased
- 1999-03-20 EP EP99922050A patent/EP1067904B1/de not_active Expired - Lifetime
- 1999-03-20 NZ NZ506988A patent/NZ506988A/en unknown
- 1999-03-20 ES ES99922050T patent/ES2168013T3/es not_active Expired - Lifetime
- 1999-03-20 HU HU0102676A patent/HU227477B1/hu not_active IP Right Cessation
- 1999-03-20 DK DK99922050T patent/DK1067904T3/da active
- 1999-03-20 CZ CZ20003481A patent/CZ300704B6/cs not_active IP Right Cessation
- 1999-03-20 CA CA002326809A patent/CA2326809C/en not_active Expired - Fee Related
- 1999-03-20 UA UA2000106082A patent/UA57615C2/uk unknown
- 1999-03-20 SI SI9930029T patent/SI1067904T1/xx unknown
- 1999-03-20 JP JP2000540809A patent/JP2002509873A/ja active Pending
- 1999-03-20 AT AT99922050T patent/ATE209899T1/de active
- 1999-03-20 BR BR9909233-6A patent/BR9909233A/pt not_active Application Discontinuation
- 1999-03-20 TR TR2000/02809T patent/TR200002809T2/xx unknown
- 1999-03-20 PL PL343199A patent/PL191266B1/pl unknown
- 1999-03-20 PT PT99922050T patent/PT1067904E/pt unknown
- 1999-03-20 WO PCT/DE1999/000799 patent/WO1999049843A1/de active IP Right Grant
- 1999-03-20 IL IL13860699A patent/IL138606A/xx not_active IP Right Cessation
- 1999-03-20 SK SK1431-2000A patent/SK284476B6/sk not_active IP Right Cessation
- 1999-03-20 DE DE59900501T patent/DE59900501D1/de not_active Expired - Lifetime
- 1999-03-20 CN CNB998046736A patent/CN1136838C/zh not_active Expired - Fee Related
- 1999-03-25 TW TW088104724A patent/TWI233808B/zh not_active IP Right Cessation
- 1999-03-26 US US09/277,403 patent/US6245353B1/en not_active Expired - Lifetime
- 1999-03-31 AR ARP990101499A patent/AR018828A1/es not_active Application Discontinuation
2000
- 2000-09-21 NO NO20004722A patent/NO329071B1/no not_active IP Right Cessation
- 2000-09-26 ZA ZA200005134A patent/ZA200005134B/xx unknown
- 2000-10-11 BG BG104843A patent/BG64741B1/bg unknown
2001
- 2001-09-25 HK HK01106751A patent/HK1036217A1/xx not_active IP Right Cessation
2002
- 2002-03-04 CY CY20021100045T patent/CY1107331T1/el unknown

Also Published As

Publication number	Publication date
SK284476B6 (sk)	2005-04-01
IL138606A0 (en)	2001-10-31
KR20010034718A (ko)	2001-04-25
PL191266B1 (pl)	2006-04-28
ES2168013T3 (es)	2002-05-16
KR100653568B1 (ko)	2006-12-05
SK14312000A3 (sk)	2001-07-10
UA57615C2 (uk)	2003-06-16
CN1136838C (zh)	2004-02-04
CY1107331T1 (el)	2012-12-19
CN1295464A (zh)	2001-05-16
CA2326809C (en)	2008-11-18
NO329071B1 (no)	2010-08-16
HUP0102676A2 (hu)	2001-11-28
TWI233808B (en)	2005-06-11
BR9909233A (pt)	2000-11-28
CZ300704B6 (cs)	2009-07-22
ATE209899T1 (de)	2001-12-15
US6245353B1 (en)	2001-06-12
BG64741B1 (bg)	2006-02-28
NZ506988A (en)	2002-05-31
DE19814256A1 (de)	1999-10-07
CA2326809A1 (en)	1999-10-07
WO1999049843A1 (de)	1999-10-07
HK1036217A1 (en)	2001-12-28
TR200002809T2 (tr)	2000-12-21
AR018828A1 (es)	2001-12-12
PL343199A1 (en)	2001-07-30
CZ20003481A3 (en)	2001-05-16
BG104843A (en)	2001-07-31
AU750140B2 (en)	2002-07-11
AU3925399A (en)	1999-10-18
NO20004722D0 (no)	2000-09-21
HU227477B1 (en)	2011-07-28
RU2216318C2 (ru)	2003-11-20
JP2002509873A (ja)	2002-04-02
IL138606A (en)	2005-07-25
DK1067904T3 (da)	2002-04-02
EP1067904B1 (de)	2001-12-05
DE59900501D1 (de)	2002-01-17
EP1067904A1 (de)	2001-01-17
SI1067904T1 (en)	2002-04-30
HUP0102676A3 (en)	2002-12-28
NO20004722L (no)	2000-09-21
PT1067904E (pt)	2002-05-31

Publication	Publication Date	Title
ZA200005134B (en)	2000-12-21	Solid, quick dissolving cetirizine formulations.
HK1044284A1 (en)	2002-10-18	Sustained release ranolazine formulations.
ZA993338B (en)	2000-11-14	Pharmaceutical formulations.
EP1025858A4 (en)	2009-03-11	DRUGS WITH REDUCED BITTERNESS ETC.
MXPA01013362A (es)	2003-09-04	Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
HK1051193A1 (en)	2003-07-25	(1,4')-Bipiperidine compounds.
HK1042653A1 (en)	2002-08-23	External preparation.
ZA200200477B (en)	2003-06-25	2-pyrazolin-5-ones.
ZA996185B (en)	2000-04-10	Sulfanylsilanes.
ZA200005136B (en)	2001-03-02	Dihydropyrimides.
ZA200108304B (en)	2003-03-26	Agrochemical formulations.
HK1054384A1 (en)	2003-11-28	4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en)	2003-09-23	Pour-on-formulations.
ZA200201829B (en)	2003-08-27	New phenylpiperazines.
HK1053470A1 (en)	2003-10-24	4-Pyridinyln-acyl-l-phenylalanines.
HK1034298A1 (en)	2001-10-19	Scaffolding.
ZA992443B (en)	1999-10-01	Hydroxy-methyl-hexanones.
HK1040488A1 (en)	2002-06-14	Pharmaceutical formulations.
ZA993473B (en)	2000-01-10	Pellet formulations.
ZA995325B (en)	2000-02-22	Methylcyclotetradec-5-en-1-ones.
ZA993123B (en)	1999-11-08	Trisresorcinyltriazines.
ZA200102716B (en)	2001-10-05	Solid pesticidal formulation.
HK1036770A1 (en)	2002-01-18	Kneader.
ZA99890B (en)	2000-08-04	Pharmaceutical compositions.
HK1057551A1 (en)	2004-04-08	Substituted 3,4-dihydro-pyridoÄ1,2-AÜpyrimidines.